Anuh Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anuh Pharma Limited has informed stock exchanges that its trading window will be closed for all insiders, designated persons, and their immediate relatives starting Wednesday, October 01, 2025. The window will remain shut until 48 hours after the company declares its unaudited financial results for the quarter and half year ended September 30, 2025. This is a standard regulatory practice under SEBI's Insider Trading Regulations, 2015 to prevent insiders from trading while in possession of unpublished financial information. The intimation was signed by Manan Vadhan, Company Secretary & Compliance Officer.
This is a routine compliance announcement and does not directly impact shareholders. However, it signals that Anuh Pharma's Q2 FY26 and H1 FY26 financial results are due soon, which investors should watch for as the next potential catalyst.